RAS effects in schizophrenia study
Part of Mental health clinical trials.
This study looks at how the renin-angiotensin system (RAS) might be linked to schizophrenia. It involves participants with schizophrenia or schizoaffective disorder who are on a stable medication. Researchers will likely measure certain brain or body functions to explore this connection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia or schizoaffective disorder.
- You are between 18 and 60 years old.
- You have been on the same antipsychotic medication and dose for at least 4 weeks.
- You are right-handed (as measured by a handedness questionnaire).
- You do not have substance abuse, neurological diseases affecting movement or hearing, or other psychiatric diagnoses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental combination treatment that targets two different brain receptors (sigma-1 and NMDA) to see if it can improve symptoms in people with schizophrenia that hasn't responded well to standard antipsychotics.
This trial tests whether “RAS training” can improve upper-limb (arm/hand) movement in people with Parkinson’s disease. It also studies how the training works and whether it improves movement in everyday tasks.
This study tests a brain stimulation treatment (neuromodulation) to improve brain connectivity in people with schizophrenia. It aims to see if this approach can help with symptoms and cognitive function.
This trial studies whether structured physical training can change brain “signal wiring” in people with schizophrenia. Researchers will also look at related molecular changes to understand why exercise might improve symptoms.
This study tests whether a non-invasive brain stimulation technique called TMS can improve brain connections in people with schizophrenia. It involves two types of MRI scans and several TMS sessions to see if it can help with thinking and symptoms.
This trial tests a type of brain stimulation called TMS to see if it can change brain connections that may be linked to symptoms. It might help people with schizophrenia or schizoaffective disorder who are stable on their current medications.
Hear when a new Schizophrenia and Schizoaffective Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.